Bio-Techne Corp. (TECH)
72.44
-0.14
(-0.19%)
USD |
NASDAQ |
Oct 06, 16:00
72.44
0.00 (0.00%)
After-Hours: 18:06
Bio-Techne Cash from Investing (Quarterly) : -7.057M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.057M |
| March 31, 2026 | -5.817M |
| December 31, 2025 | -5.921M |
| September 30, 2025 | 0.605M |
| June 30, 2025 | 0.406M |
| March 31, 2025 | -8.873M |
| December 31, 2024 | -5.032M |
| September 30, 2024 | -21.68M |
| June 30, 2024 | -8.808M |
| March 31, 2024 | -16.44M |
| December 31, 2023 | -23.67M |
| September 30, 2023 | -154.11M |
| June 30, 2023 | -4.756M |
| March 31, 2023 | -241.10M |
| December 31, 2022 | -0.109M |
| September 30, 2022 | -19.69M |
| June 30, 2022 | -18.57M |
| March 31, 2022 | -35.99M |
| December 31, 2021 | -35.17M |
| September 30, 2021 | -7.12M |
| June 30, 2021 | -226.90M |
| March 31, 2021 | 0.129M |
| December 31, 2020 | -8.604M |
| September 30, 2020 | -8.138M |
| June 30, 2020 | -10.47M |
| Date | Value |
|---|---|
| March 31, 2020 | 19.36M |
| December 31, 2019 | 33.30M |
| September 30, 2019 | -15.08M |
| June 30, 2019 | -30.32M |
| March 31, 2019 | -4.736M |
| December 31, 2018 | -13.63M |
| September 30, 2018 | -288.11M |
| June 30, 2018 | 37.97M |
| March 31, 2018 | -57.93M |
| December 31, 2017 | -6.345M |
| September 30, 2017 | -12.40M |
| June 30, 2017 | -4.701M |
| March 31, 2017 | 0.004M |
| December 31, 2016 | -38.79M |
| September 30, 2016 | -262.47M |
| June 30, 2016 | -3.618M |
| March 31, 2016 | -13.99M |
| December 31, 2015 | -4.805M |
| September 30, 2015 | -85.16M |
| June 30, 2015 | -5.522M |
| March 31, 2015 | -3.148M |
| December 31, 2014 | -62.62M |
| September 30, 2014 | -355.20M |
| June 30, 2014 | 163.77M |
| March 31, 2014 | -0.081M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Repligen Corp. | -2.089M |
| BioLife Solutions, Inc. | -1.579M |
| MindWalk Holdings Corp. | -0.0559M |
| Maravai Lifesciences Holdings, Inc. | -0.37M |
| MaxCyte, Inc. | 6.566M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 95.42M |
| Cash from Financing (Quarterly) | -33.21M |
| Free Cash Flow | 263.22M |
| Free Cash Flow Per Share (Quarterly) | 0.5536 |
| Free Cash Flow to Equity (Quarterly) | 88.17M |
| Free Cash Flow to Firm (Quarterly) | 89.09M |
| Free Cash Flow Yield | 2.32% |